SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) has begun shipping production volumes of its FLEXsixTM integrated fluidic circuits (IFCs) to genotyping and gene expression customers. The FLEXsix IFC features a unique architecture consisting of six 12-assay-by-12-sample partitions that can each be run separately or together. Customers are able to either run each partition independently as separate experiments at separate times, or run multiple partitions simultaneously - giving them new levels of flexibility for their Fluidigm-based experiments.
Help employers find you! Check out all the jobs and post your resume.
